Ignite Creation Date:
2025-12-24 @ 7:07 PM
Ignite Modification Date:
2026-01-01 @ 6:56 AM
Study NCT ID:
NCT00004057
Status:
COMPLETED
Last Update Posted:
2013-06-21
First Post:
1999-12-10
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Paclitaxel Plus L-778,123 in Treating Patients With Recurrent or Refractory Solid Tumors or Lymphomas
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
1998-12
Start Date Type:
None
Primary Completion Date:
2000-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2000-12
Completion Date Type:
ACTUAL
First Submit Date:
1999-12-10
First Submit QC Date:
None
Study First Post Date:
2004-09-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-06-20
Last Update Post Date:
2013-06-21
Last Update Post Date Type:
ESTIMATED